Bloomberg: AstraZeneca Wants To Hold Another Vaccine Trial
AstraZeneca's CEO reportedly wants to intentionally test a one-and-a-half dose regimen after receiving mixed results from the drugmaker's trial.
AstraZeneca's CEO says the company needs to conduct another global trial for its vaccine. That's according to a report from Bloomberg.
AstraZeneca initially said its vaccine showed 62 percent effectiveness when taken as a full two-dose regimen.
It also said the vaccine was up to 90 percent effective when participants were given a dose and a half. But the difference in dosages was apparently a mistake.
Some of the vials used in the trial had a lower concentration of the vaccine.
AstraZeneca's CEO wants to administer that one-and-a-half dosage intentionally and see if the 90 percent efficacy results hold up.
Walmart Offers $3.1 Billion To Settle Opioid Lawsuits
Walmart's offer would have to be approved by 43 U.S. states by Dec. 15, and local governments could sign on by March 31, 2023.By Nam Y. Huh / AP
CVS, Walgreens Announce $10B Opioid Settlement
The tentative settlement will not be final until enough states and localities sign off on it.By Gene J. Puskar / AP
Adderall Shortage Persists Across U.S. As Number Of Users Increases
A nationwide Adderall shortage is leaving patients with ADHD without medication or forcing them to switch to an alternative.By Newsy
10 Cars That Last The Longest (And 6 Are Toyotas)
A recent study analyzed more than 2 million cars to find out which may last the longest. Six Toyotas, two Chevys, a GMC and one Honda made the list.By AP
Tampa Police Chief Resigns After Dodging Traffic Ticket
Mary O'Connor submitted her resignation after an internal affairs review found she violated policy when she abused her position to escape a ticket.By Dirk Shadd / Tampa Bay Times via AP
Gay Rights And Religion Clash At The Supreme Court
A Colorado web designer is at the center of a controversial case for refusing to design websites for gay couples because of her Christian beliefs.By Andrew Harnik / AP